Managers / Q2 2019 · view latest →
Lion Point Capital, LP
CIK 0001643354 · 375 PARK AVE, SUITE 2609, NEW YORK, NY, 10152 · 212-356-6200
Summary
Lion Point Capital, LP reported $1.0B in U.S.-listed holdings across 24 positions for Q2 2019.
Its largest position, LSCC, represents 11.3% of the portfolio.
Compared with Q1 2019, the fund opened 4 new positions and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 54.9% · $558M
- ETP · 35.1% · $357M
- US DOMESTIC · 7.0% · $71M
- Other · 3.0% · $30M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| LIBERTY GLOBAL PLC | NEW | +800.0K | 800.0K | +$22M | $22M |
| PRSPPERSPECTA INC | NEW | +900.0K | 900.0K | +$21M | $21M |
| DRRXEURDURECT CORP | NEW | +18.75M | 18.75M | +$12M | $12M |
| MEDICINES CO | NEW | +12.00M | 12.00M | +$12M | $12M |
| MDCOUSDMEDICINES CO | ADDED | +350.7K | 500.7K | +$14M | $18M |
| SPDR SERIES TRUST | ADDED | +3.34M | 5.09M | +$85M | $139M |
| ZAYO GROUP HLDGS INC | ADDED | +351.3K | 633.3K | +$13M | $21M |
| FTSIEURFTS INTERNATIONAL INC | SOLD OUT | −1.66M | 0 | −$17M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | LSCCLATTICE SEMICONDUCTOR CORPhistory → | COM | 11.29% | $115M | 7.86M |
| 2 | CSIQCANADIAN SOLAR INChistory → | COM | 8.29% | $84M | 3.86M |
| 3 | ALDR1EURALDER BIOPHARMACEUTICALS INC | NOTE 2.500% 2/0 · COM | 7.21% | $73M | 64.72M |
| 4 | ACHCACADIA HEALTHCARE COMPANY INhistory → | COM | 5.67% | $58M | 1.65M |
| 5 | PDCEUSDPDC ENERGY INChistory → | COM | 5.26% | $53M | 1.48M |
| 6 | CRZOEURCARRIZO OIL & GAS INChistory → | COM | 4.61% | $47M | 4.67M |
| 7 | ARNCCHFARCONIC INChistory → | COM | 3.43% | $35M | 1.35M |
| 8 | MDCOUSDMEDICINES CO | COM · NOTE 2.750% 7/1 | 2.98% | $30M | 12.50M |
| 9 | LIBERTY GLOBAL PLC | SHS CL A | 2.13% | $22M | 800.0K |
| 10 | PRSPPERSPECTA INChistory → | COM | 2.07% | $21M | 900.0K |
| 11 | ZAYO GROUP HLDGS INC | COM | 2.05% | $21M | 633.3K |
| 12 | AAALCOA CORPhistory → | COM | 1.38% | $14M | 598.4K |
| 13 | EQTEQT CORPhistory → | COM | 1.25% | $13M | 804.5K |
| 14 | DRRXEURDURECT CORPhistory → | COM | 1.20% | $12M | 18.75M |
| 15 | SCOR1EURCOMSCORE INC | COM | 0.98% | $10M | 1.92M |
| 16 | ENCANA CORP | COM | 0.76% | $8M | 1.50M |
| 17 | LOGCUSDLOGICBIO THERAPEUTICS INC | COM | 0.64% | $7M | 500.0K |
| 18 | EXTREXTREME NETWORKS INC | COM | 0.52% | $5M | 811.8K |
| 19 | OPES ACQUISITION CORP | UNIT 03/07/2023 | 0.09% | $871,000 | 83.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $17M | 35 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $19M | 39 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $18M | 27 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $15M | 19 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $16M | 21 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $19M | 19 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $45M | 25 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $55M | 27 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $179M | 32 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $200M | 30 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $224M | 31 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $221M | 30 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $243M | 31 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $703M | 32 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $454M | 41 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $878M | 40 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $431M | 35 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $373M | 33 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $533M | 38 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $579M | 34 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $550M | 30 | May 19, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2020 | $519M | 24 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $456M | 24 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $412M | 24 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $379M | 25 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.1B | 26 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $897M | 26 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.0B | 24 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.1B | 24 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $636M | 35 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.